nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazepam—CYP2C18—malignant glioma	0.31	0.448	CbGaD
Diazepam—CYP2B6—malignant glioma	0.23	0.333	CbGaD
Diazepam—PTGS1—malignant glioma	0.152	0.219	CbGaD
Diazepam—CYP1A2—Carmustine—malignant glioma	0.0359	0.569	CbGbCtD
Diazepam—CYP3A4—Temozolomide—malignant glioma	0.0271	0.43	CbGbCtD
Diazepam—Hyperacusis—Temozolomide—malignant glioma	0.0026	0.0265	CcSEcCtD
Diazepam—Abnormal behaviour—Temozolomide—malignant glioma	0.0026	0.0265	CcSEcCtD
Diazepam—Grand mal convulsion—Carmustine—malignant glioma	0.0021	0.0214	CcSEcCtD
Diazepam—Disorder sight—Temozolomide—malignant glioma	0.00203	0.0207	CcSEcCtD
Diazepam—Faecal incontinence—Carmustine—malignant glioma	0.00198	0.0202	CcSEcCtD
Diazepam—Faecal incontinence—Temozolomide—malignant glioma	0.00192	0.0195	CcSEcCtD
Diazepam—Transaminases increased—Carmustine—malignant glioma	0.00165	0.0168	CcSEcCtD
Diazepam—Cerebration impaired—Temozolomide—malignant glioma	0.00165	0.0168	CcSEcCtD
Diazepam—Myasthenia—Carmustine—malignant glioma	0.00159	0.0162	CcSEcCtD
Diazepam—GABRR3—retina—malignant glioma	0.00156	0.0271	CbGeAlD
Diazepam—Hypokinesia—Carmustine—malignant glioma	0.00148	0.0151	CcSEcCtD
Diazepam—Digestion impaired—Temozolomide—malignant glioma	0.00145	0.0147	CcSEcCtD
Diazepam—GABRQ—telencephalon—malignant glioma	0.00144	0.025	CbGeAlD
Diazepam—GABRR2—retina—malignant glioma	0.00135	0.0235	CbGeAlD
Diazepam—Stupor—Carmustine—malignant glioma	0.00134	0.0137	CcSEcCtD
Diazepam—GABRR1—retina—malignant glioma	0.0013	0.0226	CbGeAlD
Diazepam—TSPO—blood vessel—malignant glioma	0.00128	0.0222	CbGeAlD
Diazepam—Otitis media—Temozolomide—malignant glioma	0.00124	0.0127	CcSEcCtD
Diazepam—Memory impairment—Temozolomide—malignant glioma	0.00123	0.0126	CcSEcCtD
Diazepam—Speech disorder—Carmustine—malignant glioma	0.00116	0.0119	CcSEcCtD
Diazepam—Accidental injury—Carmustine—malignant glioma	0.00113	0.0115	CcSEcCtD
Diazepam—Speech disorder—Temozolomide—malignant glioma	0.00112	0.0115	CcSEcCtD
Diazepam—Disturbance in attention—Temozolomide—malignant glioma	0.00112	0.0114	CcSEcCtD
Diazepam—Thinking abnormal—Carmustine—malignant glioma	0.00109	0.0111	CcSEcCtD
Diazepam—GABRD—telencephalon—malignant glioma	0.00104	0.0181	CbGeAlD
Diazepam—Coordination abnormal—Carmustine—malignant glioma	0.00102	0.0104	CcSEcCtD
Diazepam—GABRG1—telencephalon—malignant glioma	0.001	0.0174	CbGeAlD
Diazepam—Injection site reaction—Carmustine—malignant glioma	0.000995	0.0101	CcSEcCtD
Diazepam—Coordination abnormal—Temozolomide—malignant glioma	0.000985	0.01	CcSEcCtD
Diazepam—Respiratory failure—Temozolomide—malignant glioma	0.000985	0.01	CcSEcCtD
Diazepam—GABRB1—telencephalon—malignant glioma	0.000972	0.0169	CbGeAlD
Diazepam—Depressed level of consciousness—Carmustine—malignant glioma	0.000967	0.00985	CcSEcCtD
Diazepam—Urinary incontinence—Carmustine—malignant glioma	0.000967	0.00985	CcSEcCtD
Diazepam—GABRA5—telencephalon—malignant glioma	0.000967	0.0168	CbGeAlD
Diazepam—Urinary incontinence—Temozolomide—malignant glioma	0.000934	0.00952	CcSEcCtD
Diazepam—Depressed level of consciousness—Temozolomide—malignant glioma	0.000934	0.00952	CcSEcCtD
Diazepam—Gynaecomastia—Carmustine—malignant glioma	0.000896	0.00912	CcSEcCtD
Diazepam—Clozapine—CALY—malignant glioma	0.000893	0.214	CrCbGaD
Diazepam—Abnormal vision—Carmustine—malignant glioma	0.000873	0.00889	CcSEcCtD
Diazepam—Mental disability—Carmustine—malignant glioma	0.000869	0.00885	CcSEcCtD
Diazepam—Abnormal vision—Temozolomide—malignant glioma	0.000844	0.00859	CcSEcCtD
Diazepam—Phlebitis—Carmustine—malignant glioma	0.000844	0.00859	CcSEcCtD
Diazepam—Mental disability—Temozolomide—malignant glioma	0.00084	0.00855	CcSEcCtD
Diazepam—GABRB2—brainstem—malignant glioma	0.000827	0.0144	CbGeAlD
Diazepam—Swelling—Carmustine—malignant glioma	0.000824	0.00839	CcSEcCtD
Diazepam—GABRD—medulla oblongata—malignant glioma	0.000818	0.0142	CbGeAlD
Diazepam—GABRQ—central nervous system—malignant glioma	0.000816	0.0142	CbGeAlD
Diazepam—Injury—Carmustine—malignant glioma	0.000791	0.00805	CcSEcCtD
Diazepam—GABRG1—medulla oblongata—malignant glioma	0.000787	0.0137	CbGeAlD
Diazepam—Amnesia—Carmustine—malignant glioma	0.000774	0.00788	CcSEcCtD
Diazepam—PTGS1—endothelium—malignant glioma	0.000772	0.0134	CbGeAlD
Diazepam—GABRB1—medulla oblongata—malignant glioma	0.000764	0.0133	CbGeAlD
Diazepam—TSPO—embryo—malignant glioma	0.000763	0.0133	CbGeAlD
Diazepam—GABRA2—brainstem—malignant glioma	0.000755	0.0131	CbGeAlD
Diazepam—GABRD—midbrain—malignant glioma	0.000748	0.013	CbGeAlD
Diazepam—Amnesia—Temozolomide—malignant glioma	0.000748	0.00761	CcSEcCtD
Diazepam—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000744	0.00758	CcSEcCtD
Diazepam—Thirst—Temozolomide—malignant glioma	0.000738	0.00752	CcSEcCtD
Diazepam—GABRB2—telencephalon—malignant glioma	0.000733	0.0128	CbGeAlD
Diazepam—GABRG2—telencephalon—malignant glioma	0.000733	0.0128	CbGeAlD
Diazepam—GABRA1—brainstem—malignant glioma	0.00073	0.0127	CbGeAlD
Diazepam—Diplopia—Carmustine—malignant glioma	0.000727	0.0074	CcSEcCtD
Diazepam—GABRG1—midbrain—malignant glioma	0.00072	0.0125	CbGeAlD
Diazepam—GABRG3—central nervous system—malignant glioma	0.000715	0.0124	CbGeAlD
Diazepam—PTGS1—blood vessel—malignant glioma	0.000712	0.0124	CbGeAlD
Diazepam—Diplopia—Temozolomide—malignant glioma	0.000702	0.00715	CcSEcCtD
Diazepam—GABRG1—spinal cord—malignant glioma	0.000702	0.0122	CbGeAlD
Diazepam—TSPO—brainstem—malignant glioma	0.000699	0.0122	CbGeAlD
Diazepam—GABRB1—midbrain—malignant glioma	0.000698	0.0121	CbGeAlD
Diazepam—GABRR2—cerebellum—malignant glioma	0.000691	0.012	CbGeAlD
Diazepam—Affect lability—Temozolomide—malignant glioma	0.000691	0.00704	CcSEcCtD
Diazepam—Ataxia—Carmustine—malignant glioma	0.000683	0.00696	CcSEcCtD
Diazepam—GABRR1—central nervous system—malignant glioma	0.000681	0.0118	CbGeAlD
Diazepam—GABRB1—spinal cord—malignant glioma	0.000681	0.0118	CbGeAlD
Diazepam—TSPO—retina—malignant glioma	0.000674	0.0117	CbGeAlD
Diazepam—GABRA2—telencephalon—malignant glioma	0.00067	0.0117	CbGeAlD
Diazepam—Mood swings—Temozolomide—malignant glioma	0.000665	0.00678	CcSEcCtD
Diazepam—Ataxia—Temozolomide—malignant glioma	0.00066	0.00673	CcSEcCtD
Diazepam—Dehydration—Temozolomide—malignant glioma	0.000653	0.00665	CcSEcCtD
Diazepam—GABRQ—brain—malignant glioma	0.000648	0.0113	CbGeAlD
Diazepam—GABRA1—telencephalon—malignant glioma	0.000648	0.0113	CbGeAlD
Diazepam—Muscular weakness—Carmustine—malignant glioma	0.000641	0.00653	CcSEcCtD
Diazepam—Dysphagia—Carmustine—malignant glioma	0.000628	0.0064	CcSEcCtD
Diazepam—TSPO—telencephalon—malignant glioma	0.00062	0.0108	CbGeAlD
Diazepam—Muscular weakness—Temozolomide—malignant glioma	0.000619	0.00631	CcSEcCtD
Diazepam—Dysphagia—Temozolomide—malignant glioma	0.000607	0.00618	CcSEcCtD
Diazepam—GABRD—central nervous system—malignant glioma	0.000592	0.0103	CbGeAlD
Diazepam—Neutropenia—Carmustine—malignant glioma	0.000587	0.00598	CcSEcCtD
Diazepam—GABRD—cerebellum—malignant glioma	0.000578	0.0101	CbGeAlD
Diazepam—GABRB2—medulla oblongata—malignant glioma	0.000576	0.01	CbGeAlD
Diazepam—GABRG2—medulla oblongata—malignant glioma	0.000576	0.01	CbGeAlD
Diazepam—GABRG1—central nervous system—malignant glioma	0.00057	0.0099	CbGeAlD
Diazepam—Neutropenia—Temozolomide—malignant glioma	0.000568	0.00578	CcSEcCtD
Diazepam—Dysuria—Temozolomide—malignant glioma	0.000568	0.00578	CcSEcCtD
Diazepam—GABRG3—brain—malignant glioma	0.000567	0.00986	CbGeAlD
Diazepam—Pneumonia—Carmustine—malignant glioma	0.000563	0.00574	CcSEcCtD
Diazepam—GABRB3—telencephalon—malignant glioma	0.000563	0.00979	CbGeAlD
Diazepam—Erectile dysfunction—Temozolomide—malignant glioma	0.000559	0.00569	CcSEcCtD
Diazepam—Depression—Carmustine—malignant glioma	0.000558	0.00569	CcSEcCtD
Diazepam—GABRG1—cerebellum—malignant glioma	0.000557	0.00968	CbGeAlD
Diazepam—Photosensitivity reaction—Temozolomide—malignant glioma	0.000554	0.00564	CcSEcCtD
Diazepam—GABRB1—central nervous system—malignant glioma	0.000552	0.0096	CbGeAlD
Diazepam—Renal failure—Carmustine—malignant glioma	0.000551	0.00561	CcSEcCtD
Diazepam—GABRA5—central nervous system—malignant glioma	0.000549	0.00955	CbGeAlD
Diazepam—Urinary tract infection—Carmustine—malignant glioma	0.000544	0.00554	CcSEcCtD
Diazepam—Pneumonia—Temozolomide—malignant glioma	0.000544	0.00554	CcSEcCtD
Diazepam—GABRR1—brain—malignant glioma	0.000541	0.0094	CbGeAlD
Diazepam—GABRB1—cerebellum—malignant glioma	0.00054	0.00939	CbGeAlD
Diazepam—Depression—Temozolomide—malignant glioma	0.00054	0.0055	CcSEcCtD
Diazepam—GABRG2—midbrain—malignant glioma	0.000527	0.00916	CbGeAlD
Diazepam—GABRB2—midbrain—malignant glioma	0.000527	0.00916	CbGeAlD
Diazepam—Urinary tract infection—Temozolomide—malignant glioma	0.000526	0.00536	CcSEcCtD
Diazepam—GABRB2—spinal cord—malignant glioma	0.000514	0.00893	CbGeAlD
Diazepam—GABRG2—spinal cord—malignant glioma	0.000514	0.00893	CbGeAlD
Diazepam—Hepatobiliary disease—Temozolomide—malignant glioma	0.000512	0.00521	CcSEcCtD
Diazepam—GABRA3—central nervous system—malignant glioma	0.000511	0.00889	CbGeAlD
Diazepam—GABRA1—medulla oblongata—malignant glioma	0.000509	0.00885	CbGeAlD
Diazepam—Sinusitis—Temozolomide—malignant glioma	0.000508	0.00517	CcSEcCtD
Diazepam—Hallucination—Carmustine—malignant glioma	0.0005	0.0051	CcSEcCtD
Diazepam—Hypoaesthesia—Carmustine—malignant glioma	0.0005	0.0051	CcSEcCtD
Diazepam—Oedema peripheral—Carmustine—malignant glioma	0.000495	0.00504	CcSEcCtD
Diazepam—TSPO—medulla oblongata—malignant glioma	0.000487	0.00847	CbGeAlD
Diazepam—Visual impairment—Carmustine—malignant glioma	0.000485	0.00494	CcSEcCtD
Diazepam—Hypoaesthesia—Temozolomide—malignant glioma	0.000483	0.00492	CcSEcCtD
Diazepam—Hallucination—Temozolomide—malignant glioma	0.000483	0.00492	CcSEcCtD
Diazepam—Urinary tract disorder—Temozolomide—malignant glioma	0.00048	0.00489	CcSEcCtD
Diazepam—Oedema peripheral—Temozolomide—malignant glioma	0.000479	0.00488	CcSEcCtD
Diazepam—Urethral disorder—Temozolomide—malignant glioma	0.000476	0.00485	CcSEcCtD
Diazepam—Eye disorder—Carmustine—malignant glioma	0.00047	0.00479	CcSEcCtD
Diazepam—GABRD—brain—malignant glioma	0.00047	0.00817	CbGeAlD
Diazepam—Visual impairment—Temozolomide—malignant glioma	0.000468	0.00477	CcSEcCtD
Diazepam—GABRA1—midbrain—malignant glioma	0.000465	0.00809	CbGeAlD
Diazepam—Eye disorder—Temozolomide—malignant glioma	0.000454	0.00462	CcSEcCtD
Diazepam—GABRA1—spinal cord—malignant glioma	0.000454	0.00789	CbGeAlD
Diazepam—GABRG1—brain—malignant glioma	0.000452	0.00786	CbGeAlD
Diazepam—Cardiac disorder—Temozolomide—malignant glioma	0.000451	0.00459	CcSEcCtD
Diazepam—Arrhythmia—Carmustine—malignant glioma	0.000449	0.00457	CcSEcCtD
Diazepam—TSPO—midbrain—malignant glioma	0.000446	0.00775	CbGeAlD
Diazepam—GABRB3—medulla oblongata—malignant glioma	0.000443	0.00769	CbGeAlD
Diazepam—Angiopathy—Temozolomide—malignant glioma	0.000441	0.00449	CcSEcCtD
Diazepam—Mental disorder—Carmustine—malignant glioma	0.00044	0.00449	CcSEcCtD
Diazepam—GABRB1—brain—malignant glioma	0.000439	0.00762	CbGeAlD
Diazepam—Mazindol—SLC6A3—malignant glioma	0.000438	0.105	CrCbGaD
Diazepam—Erythema—Carmustine—malignant glioma	0.000438	0.00446	CcSEcCtD
Diazepam—Malnutrition—Carmustine—malignant glioma	0.000438	0.00446	CcSEcCtD
Diazepam—GABRA5—brain—malignant glioma	0.000436	0.00758	CbGeAlD
Diazepam—Chills—Temozolomide—malignant glioma	0.000436	0.00444	CcSEcCtD
Diazepam—TSPO—spinal cord—malignant glioma	0.000435	0.00756	CbGeAlD
Diazepam—Mental disorder—Temozolomide—malignant glioma	0.000426	0.00434	CcSEcCtD
Diazepam—Back pain—Carmustine—malignant glioma	0.000423	0.00431	CcSEcCtD
Diazepam—Erythema—Temozolomide—malignant glioma	0.000423	0.00431	CcSEcCtD
Diazepam—Malnutrition—Temozolomide—malignant glioma	0.000423	0.00431	CcSEcCtD
Diazepam—ABCB1—blood vessel—malignant glioma	0.000421	0.00731	CbGeAlD
Diazepam—GABRB2—central nervous system—malignant glioma	0.000417	0.00725	CbGeAlD
Diazepam—GABRG2—central nervous system—malignant glioma	0.000417	0.00725	CbGeAlD
Diazepam—Dysgeusia—Temozolomide—malignant glioma	0.000414	0.00422	CcSEcCtD
Diazepam—Vision blurred—Carmustine—malignant glioma	0.000412	0.0042	CcSEcCtD
Diazepam—Back pain—Temozolomide—malignant glioma	0.000409	0.00417	CcSEcCtD
Diazepam—GABRB2—cerebellum—malignant glioma	0.000407	0.00708	CbGeAlD
Diazepam—GABRG2—cerebellum—malignant glioma	0.000407	0.00708	CbGeAlD
Diazepam—GABRA3—brain—malignant glioma	0.000406	0.00706	CbGeAlD
Diazepam—Anaemia—Carmustine—malignant glioma	0.000405	0.00412	CcSEcCtD
Diazepam—GABRB3—midbrain—malignant glioma	0.000405	0.00703	CbGeAlD
Diazepam—Agitation—Carmustine—malignant glioma	0.000402	0.0041	CcSEcCtD
Diazepam—Vision blurred—Temozolomide—malignant glioma	0.000399	0.00406	CcSEcCtD
Diazepam—GABRB3—spinal cord—malignant glioma	0.000395	0.00686	CbGeAlD
Diazepam—Leukopenia—Carmustine—malignant glioma	0.000392	0.00399	CcSEcCtD
Diazepam—Anaemia—Temozolomide—malignant glioma	0.000391	0.00398	CcSEcCtD
Diazepam—Agitation—Temozolomide—malignant glioma	0.000389	0.00396	CcSEcCtD
Diazepam—Clotiazepam—CYP2C18—malignant glioma	0.000385	0.0924	CrCbGaD
Diazepam—GABRA2—central nervous system—malignant glioma	0.000381	0.00662	CbGeAlD
Diazepam—Vertigo—Temozolomide—malignant glioma	0.00038	0.00387	CcSEcCtD
Diazepam—Leukopenia—Temozolomide—malignant glioma	0.000379	0.00386	CcSEcCtD
Diazepam—GABRE—central nervous system—malignant glioma	0.000378	0.00657	CbGeAlD
Diazepam—Palpitations—Temozolomide—malignant glioma	0.000374	0.00381	CcSEcCtD
Diazepam—Myalgia—Carmustine—malignant glioma	0.000373	0.0038	CcSEcCtD
Diazepam—GABRA2—cerebellum—malignant glioma	0.000372	0.00647	CbGeAlD
Diazepam—Cough—Temozolomide—malignant glioma	0.000369	0.00376	CcSEcCtD
Diazepam—GABRA1—central nervous system—malignant glioma	0.000368	0.0064	CbGeAlD
Diazepam—Clobazam—CYP2C18—malignant glioma	0.000364	0.0873	CrCbGaD
Diazepam—Confusional state—Carmustine—malignant glioma	0.00036	0.00367	CcSEcCtD
Diazepam—Arthralgia—Temozolomide—malignant glioma	0.00036	0.00367	CcSEcCtD
Diazepam—Myalgia—Temozolomide—malignant glioma	0.00036	0.00367	CcSEcCtD
Diazepam—GABRA1—cerebellum—malignant glioma	0.00036	0.00626	CbGeAlD
Diazepam—CYP2E1—telencephalon—malignant glioma	0.000358	0.00623	CbGeAlD
Diazepam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000358	0.00364	CcSEcCtD
Diazepam—Discomfort—Temozolomide—malignant glioma	0.000356	0.00362	CcSEcCtD
Diazepam—Infection—Carmustine—malignant glioma	0.000355	0.00361	CcSEcCtD
Diazepam—TSPO—central nervous system—malignant glioma	0.000353	0.00613	CbGeAlD
Diazepam—Dry mouth—Temozolomide—malignant glioma	0.000352	0.00359	CcSEcCtD
Diazepam—Thrombocytopenia—Carmustine—malignant glioma	0.00035	0.00356	CcSEcCtD
Diazepam—Tachycardia—Carmustine—malignant glioma	0.000349	0.00355	CcSEcCtD
Diazepam—Confusional state—Temozolomide—malignant glioma	0.000348	0.00355	CcSEcCtD
Diazepam—PTGS1—telencephalon—malignant glioma	0.000345	0.006	CbGeAlD
Diazepam—Anaphylactic shock—Temozolomide—malignant glioma	0.000345	0.00352	CcSEcCtD
Diazepam—TSPO—cerebellum—malignant glioma	0.000345	0.00599	CbGeAlD
Diazepam—Infection—Temozolomide—malignant glioma	0.000343	0.00349	CcSEcCtD
Diazepam—Anorexia—Carmustine—malignant glioma	0.00034	0.00347	CcSEcCtD
Diazepam—Nervous system disorder—Temozolomide—malignant glioma	0.000339	0.00345	CcSEcCtD
Diazepam—Thrombocytopenia—Temozolomide—malignant glioma	0.000338	0.00344	CcSEcCtD
Diazepam—Skin disorder—Temozolomide—malignant glioma	0.000335	0.00342	CcSEcCtD
Diazepam—Hypotension—Carmustine—malignant glioma	0.000334	0.0034	CcSEcCtD
Diazepam—Hyperhidrosis—Temozolomide—malignant glioma	0.000334	0.0034	CcSEcCtD
Diazepam—GABRG2—brain—malignant glioma	0.000331	0.00575	CbGeAlD
Diazepam—GABRB2—brain—malignant glioma	0.000331	0.00575	CbGeAlD
Diazepam—Anorexia—Temozolomide—malignant glioma	0.000329	0.00335	CcSEcCtD
Diazepam—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000325	0.00331	CcSEcCtD
Diazepam—Insomnia—Carmustine—malignant glioma	0.000323	0.00329	CcSEcCtD
Diazepam—Paraesthesia—Carmustine—malignant glioma	0.000321	0.00327	CcSEcCtD
Diazepam—GABRB3—central nervous system—malignant glioma	0.00032	0.00557	CbGeAlD
Diazepam—Dyspnoea—Carmustine—malignant glioma	0.000318	0.00324	CcSEcCtD
Diazepam—Somnolence—Carmustine—malignant glioma	0.000318	0.00323	CcSEcCtD
Diazepam—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000314	0.0032	CcSEcCtD
Diazepam—GABRB3—cerebellum—malignant glioma	0.000313	0.00544	CbGeAlD
Diazepam—Insomnia—Temozolomide—malignant glioma	0.000312	0.00318	CcSEcCtD
Diazepam—Decreased appetite—Carmustine—malignant glioma	0.000311	0.00316	CcSEcCtD
Diazepam—Paraesthesia—Temozolomide—malignant glioma	0.00031	0.00316	CcSEcCtD
Diazepam—Gastrointestinal disorder—Carmustine—malignant glioma	0.000308	0.00314	CcSEcCtD
Diazepam—Dyspnoea—Temozolomide—malignant glioma	0.000308	0.00313	CcSEcCtD
Diazepam—Somnolence—Temozolomide—malignant glioma	0.000307	0.00313	CcSEcCtD
Diazepam—Pain—Carmustine—malignant glioma	0.000305	0.00311	CcSEcCtD
Diazepam—Constipation—Carmustine—malignant glioma	0.000305	0.00311	CcSEcCtD
Diazepam—Dyspepsia—Temozolomide—malignant glioma	0.000304	0.00309	CcSEcCtD
Diazepam—GABRA2—brain—malignant glioma	0.000302	0.00526	CbGeAlD
Diazepam—Decreased appetite—Temozolomide—malignant glioma	0.0003	0.00306	CcSEcCtD
Diazepam—GABRE—brain—malignant glioma	0.0003	0.00521	CbGeAlD
Diazepam—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000298	0.00304	CcSEcCtD
Diazepam—Fatigue—Temozolomide—malignant glioma	0.000298	0.00303	CcSEcCtD
Diazepam—Pain—Temozolomide—malignant glioma	0.000295	0.00301	CcSEcCtD
Diazepam—Constipation—Temozolomide—malignant glioma	0.000295	0.00301	CcSEcCtD
Diazepam—Feeling abnormal—Carmustine—malignant glioma	0.000294	0.003	CcSEcCtD
Diazepam—GABRA1—brain—malignant glioma	0.000292	0.00508	CbGeAlD
Diazepam—Gastrointestinal pain—Carmustine—malignant glioma	0.000292	0.00298	CcSEcCtD
Diazepam—Clotiazepam—CYP2B6—malignant glioma	0.000286	0.0686	CrCbGaD
Diazepam—Feeling abnormal—Temozolomide—malignant glioma	0.000284	0.0029	CcSEcCtD
Diazepam—Abdominal pain—Carmustine—malignant glioma	0.000282	0.00288	CcSEcCtD
Diazepam—Gastrointestinal pain—Temozolomide—malignant glioma	0.000282	0.00288	CcSEcCtD
Diazepam—CYP2E1—medulla oblongata—malignant glioma	0.000282	0.0049	CbGeAlD
Diazepam—TSPO—brain—malignant glioma	0.00028	0.00487	CbGeAlD
Diazepam—Urticaria—Temozolomide—malignant glioma	0.000274	0.00279	CcSEcCtD
Diazepam—ALB—brain—malignant glioma	0.000273	0.00475	CbGeAlD
Diazepam—Abdominal pain—Temozolomide—malignant glioma	0.000273	0.00278	CcSEcCtD
Diazepam—Clobazam—CYP2B6—malignant glioma	0.00027	0.0648	CrCbGaD
Diazepam—Hypersensitivity—Carmustine—malignant glioma	0.000263	0.00268	CcSEcCtD
Diazepam—Asthenia—Carmustine—malignant glioma	0.000256	0.00261	CcSEcCtD
Diazepam—Hypersensitivity—Temozolomide—malignant glioma	0.000254	0.00259	CcSEcCtD
Diazepam—GABRB3—brain—malignant glioma	0.000254	0.00442	CbGeAlD
Diazepam—Clomipramine—GSTP1—malignant glioma	0.000254	0.0609	CrCbGaD
Diazepam—CYP2E1—spinal cord—malignant glioma	0.000251	0.00437	CbGeAlD
Diazepam—ABCB1—embryo—malignant glioma	0.000251	0.00436	CbGeAlD
Diazepam—Asthenia—Temozolomide—malignant glioma	0.000248	0.00252	CcSEcCtD
Diazepam—Flunitrazepam—CYP2B6—malignant glioma	0.000247	0.0593	CrCbGaD
Diazepam—Diarrhoea—Carmustine—malignant glioma	0.000244	0.00249	CcSEcCtD
Diazepam—Pruritus—Temozolomide—malignant glioma	0.000244	0.00249	CcSEcCtD
Diazepam—PTGS1—spinal cord—malignant glioma	0.000242	0.00421	CbGeAlD
Diazepam—Dizziness—Carmustine—malignant glioma	0.000236	0.00241	CcSEcCtD
Diazepam—Diarrhoea—Temozolomide—malignant glioma	0.000236	0.00241	CcSEcCtD
Diazepam—Dizziness—Temozolomide—malignant glioma	0.000228	0.00232	CcSEcCtD
Diazepam—Vomiting—Carmustine—malignant glioma	0.000227	0.00231	CcSEcCtD
Diazepam—Rash—Carmustine—malignant glioma	0.000225	0.00229	CcSEcCtD
Diazepam—Dermatitis—Carmustine—malignant glioma	0.000225	0.00229	CcSEcCtD
Diazepam—Headache—Carmustine—malignant glioma	0.000224	0.00228	CcSEcCtD
Diazepam—ABCB1—retina—malignant glioma	0.000222	0.00386	CbGeAlD
Diazepam—Vomiting—Temozolomide—malignant glioma	0.000219	0.00224	CcSEcCtD
Diazepam—Rash—Temozolomide—malignant glioma	0.000218	0.00222	CcSEcCtD
Diazepam—Dermatitis—Temozolomide—malignant glioma	0.000217	0.00221	CcSEcCtD
Diazepam—CYP2B6—central nervous system—malignant glioma	0.000217	0.00377	CbGeAlD
Diazepam—Headache—Temozolomide—malignant glioma	0.000216	0.0022	CcSEcCtD
Diazepam—Nausea—Carmustine—malignant glioma	0.000212	0.00216	CcSEcCtD
Diazepam—Nausea—Temozolomide—malignant glioma	0.000205	0.00209	CcSEcCtD
Diazepam—ABCB1—telencephalon—malignant glioma	0.000204	0.00355	CbGeAlD
Diazepam—CYP2E1—central nervous system—malignant glioma	0.000204	0.00354	CbGeAlD
Diazepam—Amoxapine—SLC6A3—malignant glioma	0.000202	0.0485	CrCbGaD
Diazepam—CYP2E1—cerebellum—malignant glioma	0.000199	0.00346	CbGeAlD
Diazepam—PTGS1—central nervous system—malignant glioma	0.000196	0.00341	CbGeAlD
Diazepam—CYP2C8—brain—malignant glioma	0.000192	0.00334	CbGeAlD
Diazepam—Flurbiprofen—PTGS1—malignant glioma	0.00019	0.0456	CrCbGaD
Diazepam—Temazepam—CYP2B6—malignant glioma	0.00019	0.0455	CrCbGaD
Diazepam—Midazolam—CYP2B6—malignant glioma	0.000184	0.0441	CrCbGaD
Diazepam—CYP2B6—brain—malignant glioma	0.000172	0.003	CbGeAlD
Diazepam—CYP3A4—central nervous system—malignant glioma	0.000164	0.00285	CbGeAlD
Diazepam—CYP2E1—brain—malignant glioma	0.000162	0.00281	CbGeAlD
Diazepam—ABCB1—medulla oblongata—malignant glioma	0.00016	0.00279	CbGeAlD
Diazepam—Loxapine—SLC6A3—malignant glioma	0.000158	0.0379	CrCbGaD
Diazepam—PTGS1—brain—malignant glioma	0.000156	0.00271	CbGeAlD
Diazepam—ABCB1—midbrain—malignant glioma	0.000147	0.00255	CbGeAlD
Diazepam—ABCB1—spinal cord—malignant glioma	0.000143	0.00249	CbGeAlD
Diazepam—ABCB1—central nervous system—malignant glioma	0.000116	0.00202	CbGeAlD
Diazepam—ABCB1—cerebellum—malignant glioma	0.000113	0.00197	CbGeAlD
Diazepam—Flurbiprofen—PTGS2—malignant glioma	0.000109	0.0261	CrCbGaD
Diazepam—ABCB1—brain—malignant glioma	9.21e-05	0.0016	CbGeAlD
Diazepam—ALB—Hemostasis—AKT2—malignant glioma	8.36e-06	9.85e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.32e-06	9.8e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—IDH2—malignant glioma	8.31e-06	9.79e-05	CbGpPWpGaD
Diazepam—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	8.28e-06	9.75e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—CAT—malignant glioma	8.22e-06	9.69e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.2e-06	9.66e-05	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	8.15e-06	9.61e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—BCHE—malignant glioma	8.1e-06	9.55e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—SPHK1—malignant glioma	8.09e-06	9.53e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.07e-06	9.51e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—PIK3CD—malignant glioma	8.03e-06	9.46e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.03e-06	9.46e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—NCOR1—malignant glioma	8.01e-06	9.44e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—SLC5A5—malignant glioma	8.01e-06	9.43e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—BCAN—malignant glioma	7.96e-06	9.37e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—BCHE—malignant glioma	7.94e-06	9.35e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CYP2C18—malignant glioma	7.93e-06	9.34e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—BCHE—malignant glioma	7.92e-06	9.33e-05	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	7.89e-06	9.29e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—GSTT1—malignant glioma	7.88e-06	9.28e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PIK3CD—malignant glioma	7.87e-06	9.27e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—SLC5A5—malignant glioma	7.84e-06	9.24e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.83e-06	9.23e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—GSTT1—malignant glioma	7.83e-06	9.23e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—SLC5A5—malignant glioma	7.83e-06	9.22e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CYP2B6—malignant glioma	7.81e-06	9.2e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—NCOR1—malignant glioma	7.77e-06	9.15e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.47e-06	8.81e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.47e-06	8.8e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PTGS1—malignant glioma	7.38e-06	8.7e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.35e-06	8.66e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PTGS1—malignant glioma	7.34e-06	8.65e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.31e-06	8.62e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.21e-06	8.49e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—RAF1—malignant glioma	7.17e-06	8.45e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—IDH1—malignant glioma	7.14e-06	8.42e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—GSTT1—malignant glioma	7.03e-06	8.28e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—PIK3CB—malignant glioma	7e-06	8.25e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—SPHK1—malignant glioma	6.91e-06	8.15e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—GSTT1—malignant glioma	6.86e-06	8.09e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—BCHE—malignant glioma	6.86e-06	8.08e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PIK3CB—malignant glioma	6.86e-06	8.08e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—BCHE—malignant glioma	6.82e-06	8.04e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.81e-06	8.02e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PTGS2—malignant glioma	6.8e-06	8.01e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—SLC5A5—malignant glioma	6.78e-06	7.99e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CYP2C18—malignant glioma	6.77e-06	7.98e-05	CbGpPWpGaD
Diazepam—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	6.76e-06	7.97e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—SLC5A5—malignant glioma	6.74e-06	7.94e-05	CbGpPWpGaD
Diazepam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	6.66e-06	7.85e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PTGS1—malignant glioma	6.59e-06	7.76e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.57e-06	7.74e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.56e-06	7.73e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—CAV1—malignant glioma	6.53e-06	7.7e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—GSTP1—malignant glioma	6.45e-06	7.6e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PTGS1—malignant glioma	6.43e-06	7.58e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—IL2—malignant glioma	6.43e-06	7.58e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—IDH2—malignant glioma	6.41e-06	7.56e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—GSTT1—malignant glioma	6.41e-06	7.55e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.41e-06	7.55e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.39e-06	7.53e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.37e-06	7.51e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.35e-06	7.48e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—CAV1—malignant glioma	6.33e-06	7.46e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—GSTP1—malignant glioma	6.32e-06	7.44e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.31e-06	7.44e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—GSTP1—malignant glioma	6.3e-06	7.43e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—CAT—malignant glioma	6.28e-06	7.39e-05	CbGpPWpGaD
Diazepam—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	6.21e-06	7.31e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—CAT—malignant glioma	6.15e-06	7.24e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—CAT—malignant glioma	6.13e-06	7.23e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—BCHE—malignant glioma	6.12e-06	7.22e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—SLC5A5—malignant glioma	6.05e-06	7.13e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.05e-06	7.13e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CYP2B6—malignant glioma	6.03e-06	7.1e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PTGS1—malignant glioma	6.01e-06	7.08e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.98e-06	7.05e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—BCHE—malignant glioma	5.98e-06	7.04e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PIK3CG—malignant glioma	5.95e-06	7.01e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—NCOR1—malignant glioma	5.93e-06	6.98e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PTEN—malignant glioma	5.93e-06	6.98e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—SLC5A5—malignant glioma	5.9e-06	6.96e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.82e-06	6.85e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—NCOR1—malignant glioma	5.8e-06	6.84e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—NCOR1—malignant glioma	5.79e-06	6.82e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PIK3CG—malignant glioma	5.77e-06	6.8e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PPARG—malignant glioma	5.74e-06	6.77e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.72e-06	6.74e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.67e-06	6.68e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.61e-06	6.62e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—BCHE—malignant glioma	5.58e-06	6.58e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PPARG—malignant glioma	5.57e-06	6.56e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.54e-06	6.53e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—SLC5A5—malignant glioma	5.52e-06	6.5e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—IDH1—malignant glioma	5.51e-06	6.5e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.51e-06	6.49e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—GSTT1—malignant glioma	5.48e-06	6.45e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—VEGFA—malignant glioma	5.46e-06	6.44e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—GSTP1—malignant glioma	5.46e-06	6.43e-05	CbGpPWpGaD
Diazepam—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	5.44e-06	6.41e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—GSTP1—malignant glioma	5.43e-06	6.4e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—SPHK1—malignant glioma	5.34e-06	6.29e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—CAT—malignant glioma	5.31e-06	6.26e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—CAT—malignant glioma	5.28e-06	6.22e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PIK3CD—malignant glioma	5.23e-06	6.16e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CYP2C18—malignant glioma	5.23e-06	6.16e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.22e-06	6.15e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.17e-06	6.09e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PTGS1—malignant glioma	5.13e-06	6.05e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.11e-06	6.03e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PIK3CD—malignant glioma	5.07e-06	5.97e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—NCOR1—malignant glioma	5.02e-06	5.91e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—NCOR1—malignant glioma	4.99e-06	5.88e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.94e-06	5.82e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—GSTP1—malignant glioma	4.87e-06	5.74e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—CAV1—malignant glioma	4.83e-06	5.69e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—BCHE—malignant glioma	4.77e-06	5.62e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—GSTP1—malignant glioma	4.76e-06	5.6e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CAT—malignant glioma	4.74e-06	5.59e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—CAV1—malignant glioma	4.73e-06	5.58e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—CAV1—malignant glioma	4.72e-06	5.56e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—SLC5A5—malignant glioma	4.71e-06	5.55e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—KRAS—malignant glioma	4.64e-06	5.47e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CAT—malignant glioma	4.63e-06	5.45e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PIK3CB—malignant glioma	4.56e-06	5.37e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PTGS2—malignant glioma	4.52e-06	5.32e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.51e-06	5.31e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—NCOR1—malignant glioma	4.48e-06	5.28e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.46e-06	5.25e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—GSTP1—malignant glioma	4.44e-06	5.24e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PIK3CB—malignant glioma	4.42e-06	5.21e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.42e-06	5.2e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PIK3CG—malignant glioma	4.4e-06	5.18e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PTGS2—malignant glioma	4.38e-06	5.16e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—NCOR1—malignant glioma	4.37e-06	5.15e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CAT—malignant glioma	4.32e-06	5.09e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PIK3CG—malignant glioma	4.31e-06	5.08e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PIK3CG—malignant glioma	4.3e-06	5.07e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—PIK3CA—malignant glioma	4.27e-06	5.03e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PPARG—malignant glioma	4.25e-06	5e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—GSTT1—malignant glioma	4.23e-06	4.98e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—PIK3CA—malignant glioma	4.18e-06	4.93e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PPARG—malignant glioma	4.16e-06	4.9e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PPARG—malignant glioma	4.15e-06	4.89e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—TP53—malignant glioma	4.13e-06	4.86e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—CAV1—malignant glioma	4.09e-06	4.82e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—NCOR1—malignant glioma	4.08e-06	4.81e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—CAV1—malignant glioma	4.07e-06	4.79e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PTGS1—malignant glioma	3.96e-06	4.67e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PTEN—malignant glioma	3.94e-06	4.64e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.91e-06	4.6e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.89e-06	4.58e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PIK3CD—malignant glioma	3.87e-06	4.56e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.85e-06	4.54e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PTEN—malignant glioma	3.82e-06	4.5e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—GSTP1—malignant glioma	3.8e-06	4.47e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PIK3CD—malignant glioma	3.79e-06	4.46e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PIK3CD—malignant glioma	3.78e-06	4.46e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PIK3CG—malignant glioma	3.73e-06	4.39e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PIK3CG—malignant glioma	3.7e-06	4.36e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CAT—malignant glioma	3.69e-06	4.35e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—BCHE—malignant glioma	3.68e-06	4.34e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—CAV1—malignant glioma	3.65e-06	4.3e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.64e-06	4.29e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PPARG—malignant glioma	3.6e-06	4.24e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PPARG—malignant glioma	3.57e-06	4.21e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—CAV1—malignant glioma	3.56e-06	4.2e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—NCOR1—malignant glioma	3.49e-06	4.11e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.49e-06	4.11e-05	CbGpPWpGaD
Diazepam—ALB—Hemostasis—AKT1—malignant glioma	3.49e-06	4.11e-05	CbGpPWpGaD
Diazepam—CYP2C18—Metabolism—AKT1—malignant glioma	3.42e-06	4.02e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PIK3CB—malignant glioma	3.37e-06	3.97e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PTGS2—malignant glioma	3.34e-06	3.94e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—CAV1—malignant glioma	3.33e-06	3.92e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PIK3CG—malignant glioma	3.33e-06	3.92e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PIK3CB—malignant glioma	3.3e-06	3.89e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PIK3CB—malignant glioma	3.3e-06	3.88e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PIK3CD—malignant glioma	3.27e-06	3.86e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PTGS2—malignant glioma	3.27e-06	3.86e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PTGS2—malignant glioma	3.27e-06	3.85e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PIK3CD—malignant glioma	3.26e-06	3.84e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PIK3CG—malignant glioma	3.25e-06	3.82e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PPARG—malignant glioma	3.21e-06	3.78e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.18e-06	3.75e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PPARG—malignant glioma	3.13e-06	3.69e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.03e-06	3.57e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—GSTP1—malignant glioma	2.93e-06	3.45e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PPARG—malignant glioma	2.93e-06	3.45e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.92e-06	3.44e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PTEN—malignant glioma	2.91e-06	3.43e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PIK3CB—malignant glioma	2.85e-06	3.36e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PTEN—malignant glioma	2.85e-06	3.36e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PIK3CD—malignant glioma	2.85e-06	3.36e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CAT—malignant glioma	2.85e-06	3.36e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PTEN—malignant glioma	2.85e-06	3.36e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—CAV1—malignant glioma	2.84e-06	3.35e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PIK3CB—malignant glioma	2.84e-06	3.34e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PTGS2—malignant glioma	2.83e-06	3.33e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PTGS2—malignant glioma	2.81e-06	3.31e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—PIK3CA—malignant glioma	2.78e-06	3.27e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.72e-06	3.2e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—PIK3CA—malignant glioma	2.69e-06	3.17e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—NCOR1—malignant glioma	2.69e-06	3.17e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.67e-06	3.14e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.59e-06	3.05e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.55e-06	3e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PTGS2—malignant glioma	2.52e-06	2.97e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PPARG—malignant glioma	2.5e-06	2.95e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PIK3CB—malignant glioma	2.49e-06	2.93e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PTEN—malignant glioma	2.47e-06	2.91e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PTGS2—malignant glioma	2.46e-06	2.9e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PTEN—malignant glioma	2.45e-06	2.89e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.32e-06	2.74e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PTGS2—malignant glioma	2.3e-06	2.71e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.28e-06	2.68e-05	CbGpPWpGaD
Diazepam—CYP3A7—Metabolism—AKT1—malignant glioma	2.27e-06	2.68e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PTEN—malignant glioma	2.2e-06	2.59e-05	CbGpPWpGaD
Diazepam—PTGS1—Metabolism—AKT1—malignant glioma	2.2e-06	2.59e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—CAV1—malignant glioma	2.2e-06	2.59e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PTEN—malignant glioma	2.15e-06	2.53e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.06e-06	2.42e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—PIK3CA—malignant glioma	2.01e-06	2.37e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.01e-06	2.37e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PTEN—malignant glioma	2.01e-06	2.37e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PIK3CG—malignant glioma	2e-06	2.36e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.99e-06	2.34e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PTGS2—malignant glioma	1.97e-06	2.32e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PPARG—malignant glioma	1.93e-06	2.27e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.76e-06	2.07e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—PIK3CA—malignant glioma	1.74e-06	2.05e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—PIK3CA—malignant glioma	1.73e-06	2.04e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PTEN—malignant glioma	1.72e-06	2.02e-05	CbGpPWpGaD
Diazepam—CYP2B6—Metabolism—AKT1—malignant glioma	1.68e-06	1.98e-05	CbGpPWpGaD
Diazepam—CYP2E1—Metabolism—AKT1—malignant glioma	1.64e-06	1.94e-05	CbGpPWpGaD
Diazepam—CYP3A5—Metabolism—AKT1—malignant glioma	1.64e-06	1.93e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.55e-06	1.83e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.53e-06	1.81e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PTGS2—malignant glioma	1.52e-06	1.79e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—PIK3CA—malignant glioma	1.52e-06	1.79e-05	CbGpPWpGaD
Diazepam—CYP2C8—Metabolism—AKT1—malignant glioma	1.42e-06	1.67e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.42e-06	1.67e-05	CbGpPWpGaD
Diazepam—ALB—Metabolism—AKT1—malignant glioma	1.41e-06	1.67e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PTEN—malignant glioma	1.32e-06	1.56e-05	CbGpPWpGaD
Diazepam—CYP2C19—Metabolism—AKT1—malignant glioma	1.27e-06	1.5e-05	CbGpPWpGaD
Diazepam—ABCB1—Metabolism—AKT1—malignant glioma	1.24e-06	1.46e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.21e-06	1.43e-05	CbGpPWpGaD
Diazepam—CYP2C9—Metabolism—AKT1—malignant glioma	1.16e-06	1.36e-05	CbGpPWpGaD
Diazepam—CYP1A2—Metabolism—AKT1—malignant glioma	9.89e-07	1.16e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—PIK3CA—malignant glioma	9.34e-07	1.1e-05	CbGpPWpGaD
Diazepam—CYP3A4—Metabolism—AKT1—malignant glioma	7.63e-07	8.99e-06	CbGpPWpGaD
